8/4/2020 9:02:03 AM
Abbott Starts Study To Evaluate New Device To Treat Recurrent Atrial Fibrillation
7/23/2020 9:03:04 AM
Abbott Receives FDA Approval For Use Of Patient Controller App On Compatible Personal Apple‡ Smartphone Devices
7/20/2020 3:34:36 PM
Absolute Declares Quarterly Dividend Of C$0.08/share, Payable Aug. 31/ Record Aug. 12
7/16/2020 7:35:37 AM
Abbott Laboratories (ABT) Declares Quarterly Dividend of $ 0.36, Record Date 7/15/2020
7/16/2020 7:32:38 AM
Abbott Q2 Worldwide Sales Of $7.3 Bln Down 8.2% On Reported Basis And 5.4 % On Organic Basis
7/6/2020 7:33:51 AM
Abbott Gets FDA Approval For NexGen Gallant ICD, CRT-D Devices
6/29/2020 9:04:55 AM
Abbott, Tandem Advance Development Of Integrated Technologies For Future Automated Insulin Delivery Systems
6/26/2020 9:05:29 AM
Abbott: New Study Finds Optical Coherence Tomography Imaging Changes Treatment Decisions In 88% Of Artery Blockages
6/25/2020 10:07:20 AM
Abbott's New Data Highlight Impact Of Its Minimally Invasive Structural Heart Therapies
6/16/2020 9:10:51 AM
Abbott: New Data Show Use Of FreeStyle Libre System Reduces Diabetic Ketoacidosis-Related Hospitalization Rates
6/16/2020 9:03:46 AM
Abbott'FreeStyle Libre System Reduces All-Cause, Diabetic Ketoacidosis-Related Hospitalization Rates& Acute Diabetes
6/15/2020 7:08:40 AM
Abbott: FDA Clears FreeStyle Libre 2 ICGM System For Adults And Children Ages 4 And Older With Diabetes